Domicilium discloses 4.9% stake in Eloxx after reverse split

Domicilium reporting entities filed an amended Schedule 13G/A disclosing beneficial ownership in Eloxx Pharmaceuticals common stock.

Rhea-AI Filing Summary

Domicilium reporting entities filed an amended Schedule 13G/A disclosing beneficial ownership in Eloxx Pharmaceuticals common stock. The amendment reports 23,478 shares (4.9%) held by Domicilium Capital Partners LLC and Daniel Simon, and 9,193 shares (2.0%) held by Domicilium Real Estate Fund III LP/GP. The filing notes an 11-for-1 reverse stock split effective May 29, 2026.

The report states the shares are directly owned by advisory clients of Domicilium Capital Partners LLC and includes a Joint Filing Agreement. Reporting persons disclaim beneficial ownership except for pecuniary interest; signatures are dated 06/05/2026.

Insights

Corporate Governance Analyst

Institutional reporting clarifies ownership levels and voting/dispositive power.

The filing lists 23,478 shares (4.9%) for Domicilium Capital Partners LLC and Daniel Simon, and 9,193 shares (2.0%) for the Real Estate Fund entities, with shared voting and dispositive power shown in the table. The amendment records the impact of an 11-for-1 reverse stock split effective May 29, 2026.

Signatures and a Joint Filing Agreement are included. Cash‑flow treatment and any plans to trade the holdings are not described in the excerpt; subsequent filings would show any changes to these positions.

Institutional Ownership Specialist

Disclosure attributes holdings to advisory clients and limits individual beneficial claims.

The report states that the securities "are directly owned by advisory clients of Domicilium Capital Partners LLC," and that none of those clients may be deemed to beneficially own more than 5% of the class. The reporting persons disclaim beneficial ownership except to the extent of pecuniary interest.

This framing is typical for advisory relationships and indicates the holdings reflect client positions rather than principal stakes by the reporting entities; further position changes would appear in later amendments.

Key Figures

Domicilium Capital/Daniel Simon holdings: 23,478 shares Domicilium Real Estate Fund III holdings: 9,193 shares Reverse stock split: 11-for-1 +1 more

4 metrics

Domicilium Capital/Daniel Simon holdings 23,478 shares reported as <b>4.9%</b> of class in Item 4

Domicilium Real Estate Fund III holdings 9,193 shares reported as <b>2.0%</b> of class in Item 4

Reverse stock split 11-for-1 effective <date>May 29, 2026</date> (comment accompanying Item 4)

Signatures date 06/05/2026 report signed by Daniel Simon

Key Terms

reverse stock split, beneficially owned, Joint Filing Agreement

3 terms

reverse stock split financial

"The Common Stock...reflects a 11 for 1 reverse stock split effective May 29, 2026."

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

beneficially owned regulatory

"Amount beneficially owned: Domicilium Real Estate Fund III LP - 9,193"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Joint Filing Agreement legal

"Exhibit A - Joint Filing Agreement"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership does Domicilium report in ELOX?

The filing reports 23,478 shares (4.9%) owned by Domicilium Capital Partners LLC and Daniel Simon, and 9,193 shares (2.0%) owned by Domicilium Real Estate Fund III LP/GP, as stated in Item 4.

Does the filing say who actually owns the shares reported?

Yes. The filing states the securities "are directly owned by advisory clients of Domicilium Capital Partners LLC." The reporting persons disclaim beneficial ownership except for pecuniary interest.

Did a corporate action affect the reported share counts?

Yes. The filing includes a comment that an 11-for-1 reverse stock split became effective on May 29, 2026, and the reported share counts reflect that split.

What voting and dispositive power is disclosed?

The table shows 0 sole voting/dispositive power and shared voting and dispositive power equal to the reported share counts (e.g., 23,478 shared for Domicilium Capital Partners LLC).

Are any of the reporting persons claiming more than 5% ownership?

The filing indicates no advisory client is deemed to beneficially own more than 5% and labels Item 5 as "Ownership of 5 percent or less of a class." Reported percentages are 4.9% and 2.0%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 10:47 AM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Eloxx Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)

29014R301

(CUSIP Number)

05/27/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 29014R301

1

Names of Reporting Persons

Domicilium Real Estate Fund III LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 9,193.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 9,193.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

9,193.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.0 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: The Common Stock, $0.01 par value per share reported herein reflects a 11 for 1 reverse stock split effective May 29, 2026.

SCHEDULE 13G

CUSIP Number(s): 29014R301

1

Names of Reporting Persons

Domicilium Real Estate Fund III GP LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 9,193.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 9,193.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

9,193.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.0 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 29014R301

1

Names of Reporting Persons

Domicilium Capital Partners LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 23,478.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 23,478.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

23,478.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.9 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP Number(s): 29014R301

1

Names of Reporting Persons

Daniel Simon

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 23,478.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 23,478.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

23,478.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.9 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Eloxx Pharmaceuticals, Inc.
(b)	Address of issuer's principal executive offices: P.O. Box 274, 10 Court Street, Arlington, MA 02476
Item 2.
(a)	Name of person filing: Domicilium Real Estate Fund III LP Domicilium Real Estate Fund III GP LLC Domicilium Capital Partners LLC Daniel Simon
(b)	Address or principal business office or, if none, residence: Domicilium Real Estate Fund III LP 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092 Domicilium Real Estate Fund III GP LLC 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092 Domicilium Capital Partners LLC 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092 Daniel Simon 535 S. Kimball Ave, Suite 140 Southlake, Texas 76092
(c)	Citizenship: Domicilium Real Estate Fund III LP - Delaware Domicilium Real Estate Fund III GP LLC - Delaware Domicilium Capital Partners LLC - Delaware Daniel Simon - United States
(d)	Title of class of securities: Common Stock, $0.01 par value per share
(e)	CUSIP No.: 29014R301
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Domicilium Real Estate Fund III LP - 9,193 Domicilium Real Estate Fund III GP LLC - 9,193 Domicilium Capital Partners LLC - 23,478 Daniel Simon - 23,478
(b)	Percent of class: Domicilium Real Estate Fund III LP - 2.0% Domicilium Real Estate Fund III GP LLC - 2.0% Domicilium Capital Partners LLC - 4.9% Daniel Simon - 4.9%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Domicilium Real Estate Fund III LP - 0 Domicilium Real Estate Fund III GP LLC - 0 Domicilium Capital Partners LLC - 0 Daniel Simon - 0
	(ii) Shared power to vote or to direct the vote: Domicilium Real Estate Fund III LP - 9,193 Domicilium Real Estate Fund III GP LLC - 9,193 Domicilium Capital Partners LLC - 23,478 Daniel Simon - 23,478
	(iii) Sole power to dispose or to direct the disposition of: Domicilium Real Estate Fund III LP - 0 Domicilium Real Estate Fund III GP LLC - 0 Domicilium Capital Partners LLC - 0 Daniel Simon - 0
	(iv) Shared power to dispose or to direct the disposition of: Domicilium Real Estate Fund III LP - 9,193 Domicilium Real Estate Fund III GP LLC - 9,193 Domicilium Capital Partners LLC - 23,478 Daniel Simon - 23,478
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. All of the securities reported in this Schedule 13G are directly owned by advisory clients of Domicilium Capital Partners LLC. None of those advisory clients may be deemed to beneficially own more than 5% of the Common Stock, $0.01 par value per share.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Domicilium Real Estate Fund III LP

Signature:	s/ Daniel Simon
Name/Title:	Daniel Simon, Managing Member of its general partner
Date:	06/05/2026

Domicilium Real Estate Fund III GP LLC

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon, Managing Member
Date:	06/05/2026

Domicilium Capital Partners LLC

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon, Managing Member
Date:	06/05/2026

Daniel Simon

Signature:	/s/ Daniel Simon
Name/Title:	Daniel Simon
Date:	06/05/2026

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.

Exhibit Information

Exhibit A - Joint Filing Agreement